Login

A Financial Analyst at SilverStone Group, Inc. holding a Chemistry bachelor's degree and an MBA from Creighton University. 00:10:00

Share On Facebook Share On Twitter

Karan Keith Agarwal - Founder | CEO - Silverstone Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Allegion's Transformational Path: Stories of Aaron and Heather | John H. Stone - CEO of Allegion
00:10:00
Bob Sulentic, CBRE Group CEO, and Lars Norell, Altus Power co-founder and co-CEO, discuss the decision to go public on "Squawk on the Street."
00:10:00
Latvian Gas Market: Competitors, Prices, and Future Plans Discussed | Aigars Kalvītis, CEO, AS Latvijas Gaze.
00:00:00
Interview of Alexandre Fraichard, CEO of Genoway
00:10:00
A year ago, VTEX Co-Founder and Co-CEO Mariano Gomide de Faria discussed the growth of conversational commerce.|Gomide de Faria is our Founder and Co-Chief Executive Officer,
00:10:00
Aim to help founders across all stages to navigate and scale-up in the complex European business|Pascal Cagni,Founder & CEO,C4 Ventures
00:10:00
Navigating Challenges: Jan Bredack on Veganz Group’s Strategy Amid Rising Costs | Jan Bredack, CEO , Veganz Group AG.
00:10:00
Risky Bets: Mario Gabelli's Top Stock Picks in Infrastructure and Entertainment | Mario J. Gabelli, Chief Executive Officer , Gamco Investors Inc.
00:10:00
Pasqualino Monti Honored at CEO for LIFE Awards 2023 | Pasqualino Monti - CEO of ENAV
00:10:00
Ciena CEO Gary Smith discusses the acquisition of Cyan.
00:10:00
Celebrating Volunteer Excellence and Community Impact in the Northwest Territories
00:00:00
RLS Global - Naventus Life Science Summit - Karin Fischer, CEO, RLS Global

© 2017 - Neuhu+